DBV Technologies SA (DBVT)
14.05
-0.50
(-3.44%)
USD |
NASDAQ |
Aug 24, 16:00
14.05
0.00 (0.00%)
After-Hours: 20:00
DBV Technologies Debt to Equity Ratio : 0.0784 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0784 |
| December 31, 2025 | 0.1285 |
| September 30, 2025 | 0.3027 |
| June 30, 2025 | 0.1692 |
| March 31, 2025 | 4.298 |
| December 31, 2024 | 0.551 |
| September 30, 2024 | 0.2774 |
| June 30, 2024 | 0.1659 |
| March 31, 2024 | 0.1063 |
| December 31, 2023 | 0.1026 |
| September 30, 2023 | 0.0542 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0422 |
| March 31, 2023 | 0.0396 |
| December 31, 2022 | 0.0516 |
| September 30, 2022 | 0.0385 |
| June 30, 2022 | 0.0386 |
| March 31, 2022 | 0.1148 |
| December 31, 2021 | 0.1076 |
| September 30, 2021 | 0.0997 |
| June 30, 2021 | 0.0895 |
| March 31, 2021 | 0.0822 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cellectis SA | 2.539 |
| Akari Therapeutics Plc | 0.0373 |
| EDAP TMS SA | -12.92 |
| Autolus Therapeutics Plc | 4.915 |
| Evaxion AS | 0.7455 |
Debt to Equity Ratio Related Metrics
| Total Liabilities (Quarterly) | 62.80M |
| Current Ratio | 4.762 |
| Net Debt Paydown Yield | -0.02% |